Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • STD Quarterly: Trichomoniasis drug given FDA approval

    Clinicians now have a second option in treating trichomoniasis, which accounts for nearly one-third of the 15.4 million cases of sexually transmitted diseases (STDs) in the United States. The Food and Drug Administration (FDA) has approved Tindamax (tinidazole) for the treatment of trichomoniasis, giardiasis, intestinal amebiasis, and amebic liver abscess.
  • STD Quarterly: Help patients know risks for hepatitis

    It may be time to update your practice. According to a new survey of Americans ages 18-35, about half of respondents did not realize that hepatitis A and hepatitis B can be sexually transmitted, and an equal number said they did not know the two are vaccine-preventable.
  • Emergency contraceptive access to grow in Canada

    The condom breaks or the pill pack stays at home on a weekend vacation. What will happen next? In Canada, women in all provinces will be able to go directly to the drug store for behind-the-counter access to emergency contraception (EC), based on the direction of regulatory wheels now set in motion.
  • Update your practice when it comes to IUDs

    What is your approach when it comes to discussing intrauterine contraception? It may be time to update your practice, based on information presented at the recent clinical meeting of the Washington, DC-based American College of Obstetricians and Gynecologists (ACOG) and newly published research.
  • Injectables and implants don’t boost cancer risk

    Add the latest research finding to your counseling on progestin-only injectable and implant contraception: Results from a large U.S. study provide further evidence that these types of birth control do not raise a womans risk of breast cancer.
  • Washington Watch: Contraceptive coverage is growing, data show

    According to AGI's study, contraceptive coverage improved dramatically between 1993 and 2002 among health plans purchased by employers for their employees.In 2001 and 2002, AGI researchers surveyed insurance companies across the nation, asking whether prescription contraceptives and other comparable drugs, devices, and services were covered in the "typical" managed care plans they wrote for their employers.
  • Full August Issue in PDF

  • Wireless technology connects case managers with referral sources

    Thanks to wireless technology, case managers working in Chicagos poorest neighborhoods no longer have lengthy waits to get referrals to other agencies for their clients.
  • Incentives work in disease management initiatives 

    When new members enroll in one of Blue Cross and Blue Shield of Oklahomas (BCBSOK) health promotion programs, they receive free equipment to help them monitor their chronic disease.
  • Program cuts LOS, ED visits for kidney patients 

    A field-based disease management care program in which nurses meet face to face with members with chronic kidney disease and end-stage renal disease has resulted in dramatic decreases in emergency department (ED) visits and hospital bed days for patients managed by RMS Disease Management Services in Vernon Hills, IL, an affiliate of DaVita Inc.